September 1997

Basic science/medicine

Proffered papers

Renal and testicular cancer

A randomized clinical trial comparing SC interleukin-2, SC Alpha-2A-interferon, and IV bolus 5-fluorouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients
• J. Atzpodien,
• H. Kirchner,
• A. Franzke,
• ...
• F. Wittke,
• R. Hoffmann,
• A. Ganser
Published in issue: September 1997
S36-S37
Survival in renal cell carcinoma (RCC)— A randomised evaluation of tamoxifen versus interleukin-2, α-interferon (leukocyte) and tamoxifen
• R. Henriksson,
• S. Nilsson,
• S. Colleen,
• ...
• M. Helsing,
• R. Zimmerman,
• K. Engman
Published in issue: September 1997
S37
Testis cancer: Carcinoma-in-situ in testes with germ cell tumour
• T.S. Poltek,
• H. Lauke,
• M. Hartmann
Published in issue: September 1997
S37
Early stage testicular seminoma — A prospective multicenter trial
• J. Classen,
• H. Schmidberger,
• R. Souchon,
• M. Bamberg
Published in issue: September 1997
S37
Lessons from prospective multicenter study on seminomas
• L. Weißbach,
• R. Bussar-Maalz,
• U. Lõhrs,
• K. Mann,
• G. Schubert
Published in issue: September 1997
S37
Long-term survival and late toxicities after high-dose chemotherapy in patients suffering from germ cell cancer
• O. Rick,
• J. Beyer,
• N. Schwella,
• ...
• A. Krusch,
• D. Huhn,
• W. Siegert
Published in issue: September 1997
S37-S38
Long-term effects of testicular cancer treatment on sexual functioning
• J.T. Hartmann,
• C. Albrecht,
• L. Kanz,
• C. Bokemeyer
Published in issue: September 1997
S38
Telomerase activity and telomere length in testicular cancer tissues and residual tumor mass after cisplatin based chemotherapy
• A.M. Burger,
• H.H. Fiebig,
• P. Hamden
Published in issue: September 1997
S38
Germ cell tumor (GCT): Staging and therapy control with ¹⁸FDG-PET. First results of German multicenter trial
• M. de Wit,
• C. Bokemeyer,
• D. Hartmann,
• ...
• M. Clauß,
• D.K. Hossfeld,
• R. Bares
Published in issue: September 1997
S38
Prognostic risk factors in low stage testicular nonseminomatous germ cell tumors (NSGCT)
• A. Heidenreich,
• K.F. Mostofi,
• I.A. Sesterhenn,
• J.W. Moul,
• U.H. Engelmann
Published in issue: September 1997
S38-S39
BOMP/EPI intensive chemotherapy in poor-prognosis Germ Cell Tumors (GCT)
• J.M. Tabemero,
• X. Garcia del Muro,
• E. Alba,
• ...
• J. Montesinos,
• M. Martínez,
• J.R. Germá
Published in issue: September 1997
S39
Secretion of immunomodulating GM-CSF and M-CSF by human renal cell carcinoma of different types
• P. Reinecke,
• K. Jaquet,
• M. Schmitz,
• E.M. Schneider,
• H.E. Gabbert,
• C.D. Gerharz
Published in issue: September 1997
S39
Autoimmunity induced by interleukin-2 and interferon-α is associated with long-term survival in patients with metastatic renal cell carcinoma
• A. Franzke,
• M. Probst,
• J. Buer,
• ...
• H. Kirchner,
• A. Ganser,
• J. Atzpodien
Published in issue: September 1997
S39
Single agent carboplatin or radiotherapy as adjuvant in stage I seminoma — Results of a prospective trial
• T. Wiegel,
• S. Sautter,
• C. Winter,
• S. Weinknecht,
• W. Hinkelbein
Published in issue: September 1997
S39
Immunochemotherapy (IC) in patients with metastatic renal cell carcinoma
• D. Samland,
• F. Steinbach,
• F. Reiher,
• E.P. Allhoff
Published in issue: September 1997
S39-S40
Results and prognostic factors after surgical treatment of lung metastases in renal cell carcinoma
• H.-S. Hofmann,
• H. Neef,
• H.R. Zerkowski
Published in issue: September 1997
S40
Intensified salvage therapy for germ cell cancer using sequential cycles of high dose carboplatin/etoposlde/cyclo-phosphamlde (CEC)
• A. Harstrick,
• A. Fosså,
• E. Zasadzinski,
• ...
• M.R. Nowrousian,
• J. Schütte,
• S. Seeber
Published in issue: September 1997
S40
Paclitaxel (P) and cisplatin (C) as salvage treatment for nonseminomatous germ cell tumor (NSGCT) patients (pts)
• S. Tjulandin,
• D. Titov,
• V. Breder,
• N. Sidorova,
• A. Popov,
• A. Garin
Published in issue: September 1997
S40
TGF-ß₁ resistance as a major progression factor in human renal cell carcinoma
• U. Ramp,
• K. Jaquet,
• P. Reinecke,
• T. Nitsch,
• H.E. Gabbert,
• C.D. Gerharz
Published in issue: September 1997
S40
Bilateral testicular germ cell tumors (TGCT)
• A. Gerl,
• M. Hentrich,
• C. Clemm,
• R. Hartenstein,
• T. Schuster,
• W. Wilmanns
Published in issue: September 1997
S40-S41
Nuclear accumulation of wildtype p53 protein cannot be related to complex formation with mdm2 in human renal cell carcinoma cell lines
• K. Jaquet,
• T. Kalinski,
• S. Hohn,
• ...
• R. Langen,
• H.E. Gabbert,
• C.-D. Gerharz
Published in issue: September 1997
S41
Germ cell tumors (GCT) in men with HIV infection
• M. Hentrich,
• N. Brack,
• T. Schuster,
• Ch. Clemm,
• R. Hartenstein
Published in issue: September 1997
S41
Bilateral germ cell tumors of the testis (GCTT): Report of two institutions experience
• Dj. Argirovic,
• Lj.R. Jelic,
• L.P. Cvetkovic,
• J. Hadzi-Djokic,
• S. Micic,
• A. Starcevic-Bozovic
Published in issue: September 1997
S41
Interferon-gamma (IFN-g) and interleukln-2 (IL-2) is a feasible and effective out-patient regimen for edvanced renal cell cancer
• G.G. Steger,
• M.P. Djavanmard,
• B. Steiner,
• ...
• H. Huber,
• M. Marberger,
• C. Zielinskl
Published in issue: September 1997
S41
Chromophilic renal cell carcinoma: Characterization of four permanent cell lines
• U. Ramp,
• B. Hildebrandt,
• R. Moll,
• K. Jaquet,
• H.E. Gabbert,
• C.D. Gerharz
Published in issue: September 1997
S42
Cisplatin, etoposide and bleomycin infusion (PEBI regimen) in good-risk patients with germ cell tumors
• M. Colleoni,
• R. Graffeo,
• G. Martinelli,
• ...
• G. Marini,
• F. Cavalli,
• A. Goldhirsch
Published in issue: September 1997
S42
Phase II study of interferon gamma (rIFN-G) and vinblastine(VBL) in patients with advanced renal cell carcinoma (RCC)
• C. Bacoyiannis,
• M.A. Dimopoulos,
• C. Nicolaides,
• ...
• D. Skarlos,
• N. Pavlidis,
• P. Kosmidis
Published in issue: September 1997
S42
Paclitaxel-induced growth supression and morphological alterations in different types of human renal cell carcinoma
• P. Reinecke,
• J. Corvin,
• H.E. Gabbert,
• C.D. Gerharz
Published in issue: September 1997
S42
Radiotherapy in stage I and II seminoma
• Lj.R. Jelić,
• L. Pavlović,
• J. Stanković
Published in issue: September 1997
S42
Testis cancer: Endocrinological disturbancies
• T.S. Pottek,
• H. Bűttner,
• M. Hartmann
Published in issue: September 1997
S42-S43
Testicular cancer: Human placental alkaline phosphatase (hPLAP)
• T.S. Pottek,
• H. Bűttner,
• M. Hartmann
Published in issue: September 1997
S43
Evaluation of the role of a single cycle of carboplatin as an adjuvant treatment in stage I seminoma and as a neo-adjuvant prior to radiotherapy in stage II
• M. Faris,
• D. Morey,
• A. Cole,
• M. Mason
Published in issue: September 1997
S43
Prognostic factors in renal carcinoma
• U. Rűther,
• K. Grunert,
• R. Sessler,
• ...
• M. Camara,
• F. Eisenberger,
• P. Jipp
Published in issue: September 1997
S43
Prognostic factors in the management of clinical stage I (CS I) nonsemlnomatous germ ceil tumors of the testis (NSGCTT)
• D. Ondruš,
• P. Bujdák,
• J. Búbravický,
• ...
• M. Mikloši,
• D. Sablová,
• J. Štefančik
Published in issue: September 1997
S43
Combination chemotherapy (CT) and secondary resection (SR) results in germ cell testicular cancer (TT)
• C. Cebotaru,
• N. ghilezan,
• N. Todor,
• T.E. Ciuleanu
Published in issue: September 1997
S44

Angiogenesis and tumour markers

Combretastatin A-4, an agent that displays selective toxicity towards tumour vasculature
• D. Chaplin,
• S. Prise,
• G. Tozer,
• G. Pettit,
• G. Dark
Published in issue: September 1997
S44
Homeobox genes expression in endothelial cells and their potential role in angiogenesis
• D. Belotti,
• N. Clausse,
• Y. Alami,
• ...
• D. Flagiello,
• M.F. Poupon,
• V. Castronovo
Published in issue: September 1997
S44
A high pretreatment serum level of VEGF is associated with poor outcome in small cell lung cancer
• H. Joensuu,
• P. Salven,
• T. Routsalainen,
• K. Mattson
Published in issue: September 1997
S44
Focal expression of platelet-derlved endothelial cell growth factor (PD-ECGF)triggers local neo-angiogenesls in non-small cell lung cancer
• A. Giatromanolaki,
• M.I. Koukourakis,
• S. Koukouraki,
• K.J. O’Byrne,
• K.C. Gatter,
• A.L. Harris
Published in issue: September 1997
S44-S45
A prospective study on Intratumoral microvessel density (IMD), p53-protein expression and prognosis in colorectal cancer
• P. Vermeulen,
• A. Pawinsky,
• E. Van Marck,
• ...
• G. Goovaerts,
• A. Van Oosterom,
• L.Y. Dirix
Published in issue: September 1997
S45
Involvement of Rho proteins in regulation of transformation and apoptosls
• P. Esteve,
• N. Embade,
• R. Perona,
• ...
• J. León,
• L. Peso,
• J.C. Lacal
Published in issue: September 1997
S45
PCR based detection of melanoma cells: Molecular staging?
• U. Keilholz,
• M. Willhauck
Published in issue: September 1997
S45
Cell-cycle dependant expression of the proliferation associated Ki-67 antigen
• M. Duchrow,
• M. Zingler,
• C. Gerlach,
• H.-P. Bruch,
• R. Broll
Published in issue: September 1997
S45
Adhesion and invasion of follicular thyroid cancer is regulated by vascular endothelial growth factor (VEGF) in vitro
• Th. Hoelting,
• Q.Y. Duh,
• O.H. Clark,
• Ch. Herfarth
Published in issue: September 1997
S46
Detection of circulating vascular endothelial growth factor (VEGF).matrix metalloprotelnase-3(MMP-3)and-9 (MMP-9) in gastrointestinal cancer
• I. Hyodo,
• T. Doi,
• H. Endo,
• ...
• Y. Nishikawa,
• M. Tanimizu,
• K. Jinno
Published in issue: September 1997
S46
Determination of changes of tissue-specific genes expression in human brain tumors
• V. Kavsan,
• V. Dmitrenko,
• O. Garifulin
Published in issue: September 1997
S46
Cyotokines and surrogate markers in HIV-related opportunistic malignancies
• A. Torresin,
• G. Cassola,
• G. Penco,
• C. Giuliano,
• A. Campanella,
• N. Piersatelli
Published in issue: September 1997
S46
Detection of tumor progression in NSCLC stage IIIB/IV patients by serial measurement of CYFRA 21-1, TPA-M. TPS, and CEA
• W. Ebert,
• M. Hoppe,
• T.H. Muley,
• P. Drings
Published in issue: September 1997
S46-S47
Comparison of the in vitro cytotoxicity of the antitumour antibiotics bleomycin and mitomycin on human colorectal cancer cells and endothelial cells
• L. Dirix,
• P. Vermeulen,
• L. Libura,
• ...
• A. Pawinsky,
• E.A. De Bruljn,
• A. Van Oosterom
Published in issue: September 1997
S47
The influence of theobromine on angiogenic activity of human ovarian cancer cells
• E. Barcz,
• P. Janik,
• K. Gawrychowski,
• E. Sommer,
• E. Skopińska-Rόżwska
Published in issue: September 1997
S47